MEI Pharma to sell 29.24M shares at $3.42 in private placement
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 18 2025
0mins
Should l Buy ?
Investment Announcement: MEI Pharma has secured a private investment in public equity, raising approximately $100 million by selling 29,239,767 shares at $3.42 each, with the closing expected around July 22.
Board and Advisory Appointments: Charlie Lee will join MEI's board of directors, and GSR will act as its digital asset advisor to implement a Litecoin Treasury Strategy, supported by various crypto venture capital firms.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
